You are using an outdated browser. Please upgrade your browser to improve your experience.


Ligand Summary
Aducanumab-avwa is a human, immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble and insoluble forms of amyloid beta. The accumulation of amyloid beta plaques in the brain is a defining pathophysiological feature of Alzheimer’s disease. ADUHELM reduces amyloid beta plaques, as evaluated in Studies 1, 2, and 3.
Synonyms & Links
DrugCentral: 5464
LyCHI:  aducanumab

Target Activities